Preoperative dual antiplatelet therapy increases bleeding and transfusions but not mortality in acute aortic dissection type A repair.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Hansson, Emma CGeirsson, Arnar
Hjortdal, Vibeke
Mennander, Ari
Olsson, Christian
Gunn, Jarmo
Zindovic, Igor
Ahlsson, Anders
Nozohoor, Shahab
Chemtob, Raphaelle A
Pivodic, Aldina
Gudbjartsson, Tomas
Jeppsson, Anders
Issue Date
2019-07-01
Metadata
Show full item recordCitation
Hansson EC, Geirsson A, Hjortdal V, Mennander A, Olsson C, Gunn J, Zindovic I, Ahlsson A, Nozohoor S, Chemtob RA, Pivodic A. Preoperative dual antiplatelet therapy increases bleeding and transfusions but not mortality in acute aortic dissection type A repair. European Journal of Cardio-Thoracic Surgery. 2019 Jan 16;56(1):182-8.Abstract
OBJECTIVES: Acute aortic dissection type A is a life-threatening condition, warranting immediate surgery. Presentation with sudden chest pain confers a risk of misdiagnosis as acute coronary syndrome resulting in subsequent potent antiplatelet treatment. We investigated the impact of dual antiplatelet therapy (DAPT) on bleeding and mortality using the Nordic Consortium for Acute Type A Aortic Dissection (NORCAAD) database. METHODS: The NORCAAD database is a retrospective multicentre database where 119 of 1141 patients (10.4%) had DAPT with ASA + clopidogrel (n = 108) or ASA + ticagrelor (n = 11) before surgery. The incidence of major bleeding and 30-day mortality was compared between DAPT and non-DAPT patients with logistic regression models before and after propensity score matching. RESULTS: Before matching, 51.3% of DAPT patients had major bleeding when compared to 37.7% of non-DAPT patients (P = 0.0049). DAPT patients received more transfusions of red blood cells [median 8 U (Q1-Q3 4-15) vs 5.5 U (2-11), P < 0.0001] and platelets [4 U (2-8) vs 2 U (1-4), P = 0.0001]. Crude 30-day mortality was 19.3% vs 17.0% (P = 0.60). After matching, major bleeding remained significantly more common in DAPT patients, 51.3% vs 39.3% [odds ratio (OR) 1.63, 95% confidence interval (CI) 1.05-2.51; P = 0.028], but mortality did not significantly differ (OR 0.88, 95% CI 0.51-1.50; P = 0.63). Major bleeding was associated with increased 30-day mortality (adjusted OR 2.44, 95% CI 1.72-3.46; P < 0.0001). CONCLUSIONS: DAPT prior to acute aortic dissection repair was associated with increased bleeding and transfusions but not with mortality. Major bleeding per se was associated with a significantly increased mortality. Correct diagnosis is important to avoid DAPT and thereby reduce bleeding risk, but ongoing DAPT should not delay surgery.Description
To access publisher's full text version of this article click on the hyperlink belowAdditional Links
https://academic.oup.com/ejcts/article-abstract/56/1/182/5290000?redirectedFrom=fulltextae974a485f413a2113503eed53cd6c53
10.1093/ejcts/ezy469
Scopus Count
Collections
Related articles
- Outcome After Surgery for Acute Aortic Dissection: Influence of Preoperative Antiplatelet Therapy on Prognosis.
- Authors: Chemtob RA, Moeller-Soerensen H, Holmvang L, Olsen PS, Ravn HB
- Issue date: 2017 Apr
- Recombinant factor VIIa use in acute type A aortic dissection repair: A multicenter propensity-score-matched report from the Nordic Consortium for Acute Type A Aortic Dissection.
- Authors: Zindovic I, Sjögren J, Ahlsson A, Bjursten H, Fuglsang S, Geirsson A, Ingemansson R, Hansson EC, Mennander A, Olsson C, Pan E, Ullén S, Gudbjartsson T, Nozohoor S
- Issue date: 2017 Dec
- Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting.
- Authors: Nagashima Z, Tsukahara K, Uchida K, Hibi K, Karube N, Ebina T, Imoto K, Kimura K, Umemura S
- Issue date: 2017 Jan
- The Nordic Consortium for Acute type A Aortic Dissection (NORCAAD): objectives and design<sup/>.
- Authors: Geirsson A, Ahlsson A, Franco-Cereceda A, Fuglsang S, Gunn J, Hansson EC, Hjortdal V, Jarvela K, Jeppsson A, Mennander A, Nozohoor S, Olsson C, Wickbom A, Zindovic I, Gudbjartsson T
- Issue date: 2016 Oct - Dec
- Prevalence, indications and appropriateness of antiplatelet therapy in patients operated for acute aortic dissection: associations with bleeding complications and mortality.
- Authors: Hansson EC, Dellborg M, Lepore V, Jeppsson A
- Issue date: 2013 Jan